.jpg)
Top Products
CPHI Pharmaceutical Products, Companies and News
News WHO says monkeypox not a health emergency, but leaders ‘deeply concerned’
The UN agency convened a meeting last week to discuss the outbreak
News Pfizer hit with patent infringement lawsuit over COVID-19 drug Paxlovid
A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain.
Pharmaceutical Industry Content
Pharmaceutical Industry Webinars
-
Webinar Common Stumbling Blocks When Outsourcing an Injectable Project to a CMO and How to Avoid Them
-
June 28th, 2022
-
4pm CET, 10am EST
-
-
Webinar The Digitalization of Autoinjector Manufacturing Webinar
-
June 22nd, 2022
-
4pm CET, 10am EST
-
-
Webinar How Small/Mid-Size Firms are Shaping the Healthcare M&A Market
-
April 28th, 2022
-
4pm CET / 11am EST / 10am CST
-
-
Webinar Technology & Device Trends Driving Care from Hospital to Home
-
March 29th, 2022
-
4pm CET / 10am EST
-
-
Webinar Rapid Tech Transfer of Vaccine Products
-
February 24th, 2022
-
4pm CET / 10am EST / 9am CST
-
-
Webinar The Future of Biomanufacturing: Capacity, Capability and Careers
-
February 22, 2022
-
4pm CET / 10am EST
-
-
Webinar Building Supply Chain Integrity and Resilience
-
January 26th 2022
-
4pm CET / 10am EST
-
-
Webinar Be Prepared! Combination Products under MDR - Article 117
-
November 24th, 2021
-
4PM CET
-
-
Webinar Reinvent Aseptic Processing with Flexible Robotics
-
November 16th, 2021
-
5pm CET / 11am EST
-
-
Webinar Defining and Designing Patient-Centric Dosage Forms
-
October 19th, 2021
-
4pm CET / 10am EST
-
-
Webinar Parenteral Drug Market: Meeting Escalating Challenges
-
September 28th, 2021
-
4pm CET / 10am EST / 3PM BST
-
Sponsored Pharmaceutical Industry News
-
Sponsored Content Croda: Solutions for Your High Value Drug Products
Formulating a drug for parenteral delivery comes with its fair set of challenges. Aside from a high level of sensitivity to external factors like light and heat exposure, these large and complex drugs are prone to degradation when exposed to various ch... -
Sponsored Content Audits in the time of COVID-19 – Implications for a CMO
Travel restrictions imposed by the pandemic have limited the ability of pharmaceutical companies and health authority personnel to travel and conduct in-person inspections of contract manufacturing organizations (CMOs). Due to t... -
Sponsored Content Avanti & Croda-Denmark: Advancing Vaccine Adjuvant Research
Adjuvants. You’ve seen them on our website. You’ve seen them featured in our blog articles. Now we want to show you how Avanti’ & Croda-Denmark can enhance your vaccine adjuvant research! Keep reading to learn more! -
News Recipharm streamlines operations by selling oral solid dosage manufacturing site
Astrea Pharma will be the new owner of the facility at Fontaine-lès-Dijon -
News SHL Medical publishes its Molly® modular platform technology white paper
This white paper is a retrospective analysis on how the new generation of Molly autoinjectors have incorporated a greater level of flexibility in its design and development model. -
News Adare Pharma acquires oral formulations specialist Frontida BioPharm
The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges -
News Medinfar awarded first ever CPHI Verified Certificate
CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark -
News China sees huge bounce in pharma rankings ahead of hybrid CPHI & P-MEC China
China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships -
News Lonza Switzerland site to undergo expansion of microbial development capabilities
The expansion includes the installation of a pilot suite with a 50-L fermenter and automation upgrades to accelerate clinical and commercial projects -
News Almac to employ 1,800 people in global recruitment drive
The CDMO will raise its headcount to 8,000 across its 19 global facilities amid increased demand for services -
News Viral vector demand to flourish on wave of imminent approvals, CPHI Worldwide audience told
Expected increase in approvals for gene therapies, gene-modified cell therapies and recombinant vector vaccines will also increase pressure on manufacturers to build new capacity -
News Catalent embarks on $230M viral vector expansion project at Harmans campus
By completion at the end of 2022, the campus will accommodate 18 cGMP viral vector manufacturing suites
